Primary Care > > Diabetes– Dexcom’s Stelo system offered without a prescription by the summer season
by Kristen Monaco, Senior Staff Writer, MedPage Today March 6, 2024
The very first non-prescription constant glucose display (CGM) was cleared for usage by grownups with or without diabetes, the FDA revealed on Tuesday.
The Dexcom Stelo Glucose Biosensor System is an incorporated CGM (iCGM) that will be offered without a prescription for grownups with type 2 diabetes who do not utilize insulin, such as those who just handle their condition with oral representatives.
And following a current social networks pattern, the gadget is likewise cleared for grownups without diabetes who wish to much better comprehend how diet plan and workout might affect blood glucose levels.
“CGMs can be an effective tool to assist keep track of blood sugar. Today’s clearance broadens access to these gadgets by permitting people to acquire a CGM without the participation of a doctor,” Jeff Shuren, MD, JD, director of the FDA’s Center for Devices and Radiological Health, stated in a declaration. “Giving more people important info about their health, no matter their access to a medical professional or medical insurance, is an essential advance ahead of time health equity for U.S. clients.”
That being stated, the gadget is not suggested for clients with troublesome hypoglycemia given that it’s not created to inform for low blood glucose levels like other systems.
The Stelo iCGM system includes a wearable sensing unit– endured the back of the arm for approximately 15 days before replacement– paired with a smart device or wise gadget application to constantly determine, record, examine, and show glucose worths. It can supply blood sugar measurements every 15 minutes on the app.
“Users ought to not make medical choices based upon the gadget’s output without speaking with their doctor,” the FDA alerted.
Underpinning the clearance were medical research study information that revealed comparable efficiency of the Stelo Glucose Biosensor System with other comparable iCGMs. Throughout the research study, the most typical negative occasions were likewise comparable to those of other iCGMs, consisting of regional infection, skin inflammation, and discomfort or pain. About 78% of sensing units lasted the complete 15 days throughout the research study.
Maker Dexcom stated Stelo will be readily available for purchase online without a prescription this summertime.
-
Kristen Monaco is a senior personnel author, concentrating on endocrinology, psychiatry, and nephrology news. Based out of the New York City workplace, she’s operated at the business considering that 2015.
